Literature DB >> 3872269

The phthalocyanines: a new class of mammalian cells photosensitizers with a potential for cancer phototherapy.

E Ben-Hur, I Rosenthal.   

Abstract

Phthalocyanines, porphyrin-like compounds with maximum absorption in the red, which were previously reported to localize selectively in tumours, have been shown to be efficient photosensitizers of mammalian cells in culture, thus making them possible candidates to replace haematoporphyrin derivatives in cancer phototherapy.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3872269     DOI： 10.1080/09553008514550211

Source DB:  PubMed          Journal:  Int J Radiat Biol Relat Stud Phys Chem Med        ISSN： 0020-7616


  16 in total

1.  Photodynamic sensitization of Leishmania amazonensis in both extracellular and intracellular stages with aluminum phthalocyanine chloride for photolysis in vitro.

Authors:  Sujoy Dutta; Debalina Ray; Bala K Kolli; Kwang-Poo Chang
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

2.  Development of a novel formulation with hypericin to treat cutaneous leishmaniasis based on photodynamic therapy in in vitro and in vivo studies.

Authors:  Andrés Montoya; Alejandro Daza; Diana Muñoz; Karina Ríos; Viviana Taylor; David Cedeño; Iván D Vélez; Fernando Echeverri; Sara M Robledo
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

3.  Non-monotonic changes in clonogenic cell survival induced by disulphonated aluminum phthalocyanine photodynamic treatment in a human glioma cell line.

Authors:  Seema Gupta; Bilikere S Dwarakanath; K Muralidhar; Tulay Koru-Sengul; Viney Jain
Journal:  J Transl Med       Date:  2010-04-30       Impact factor: 5.531

4.  Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers.

Authors:  R Bonnett; R D White; U J Winfield; M C Berenbaum
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

Review 5.  Current status of photodynamic therapy in oncology.

Authors:  R van Hillegersberg; W J Kort; J H Wilson
Journal:  Drugs       Date:  1994-10       Impact factor: 9.546

6.  Liposome- or LDL-administered Zn (II)-phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency.

Authors:  E Reddi; C Zhou; R Biolo; E Menegaldo; G Jori
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

7.  CGP 55398, a liposomal Ge(IV) phthalocyanine bearing two axially ligated cholesterol moieties: a new potential agent for photodynamic therapy of tumours.

Authors:  A Segalla; C Milanesi; G Jori; H G Capraro; U Isele; K Schieweck
Journal:  Br J Cancer       Date:  1994-05       Impact factor: 7.640

8.  meso-Tetra(hydroxyphenyl)porphyrins, a new class of potent tumour photosensitisers with favourable selectivity.

Authors:  M C Berenbaum; S L Akande; R Bonnett; H Kaur; S Ioannou; R D White; U J Winfield
Journal:  Br J Cancer       Date:  1986-11       Impact factor: 7.640

9.  Cell uptake, distribution and response to aluminium chloro sulphonated phthalocyanine, a potential anti-tumour photosensitizer.

Authors:  W S Chan; R Svensen; D Phillips; I R Hart
Journal:  Br J Cancer       Date:  1986-02       Impact factor: 7.640

10.  Photodynamic therapy with porphyrin and phthalocyanine sensitisation: quantitative studies in normal rat liver.

Authors:  S G Bown; C J Tralau; P D Smith; D Akdemir; T J Wieman
Journal:  Br J Cancer       Date:  1986-07       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.